ClinicalTrials.gov
public full text
Public Domain
A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism
This clinical study aims to evaluate the safety and efficacy of repeated dosing of recombinant human parathyroid hormone (rhPTH\[1-84\]) in Japanese participants with chronic hypoparathyroidism for a 26-week period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Registry for Participants With Chronic Hypoparathyroidism#1138940
- A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism#866902
- AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism#1164224
- Vermeidung, Prädiktion und postoperatives Management des Hypoparathyreoidismus nach Schilddrüseneingriffen#406790
- A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism#1150373
Record · ID 886891
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive